tailieunhanh - Commercializing the stem cell sciences

Since stem cells were first isolated from a human embryo in 1998, interest in the development of a global stem cell market has grown exponentially. Prior to this, while the existence of human embryonic stem cells had long been established, it was thought impossible to isolate them with any degree of success. The 1998 discovery opened up a new avenue of research that subsequently became one of the world’s hottest topics. | Woodhead publishing series in biomedicine COMMERCIALIZING THE STEM CELL SCIENCES OLIVIA HARVEY WOODHEAD PUBLISHING Commercializing the stem cell sciences Woodhead Publishing Series in Biomedicine 1 2 3 4 5 6 7 8 9 10 11 12 Practical leadership for biopharmaceutical executives . Chin Outsourcing biopharma R D to India P. R. Chowdhury Matlab in bioscience and biotechnology L. Burstein Allergens and respiratory pollutants Edited by . Williams Concepts and techniques in genomics and proteomics N. Saraswathy and P. Ramalingam An introduction to pharmaceutical sciences J. Roy Patently innovative How pharmaceutical firms use emerging patent law to extend monopolies on blockbuster drugs . Bouchard Therapeutic protein drug products Practical approaches to formulation in the laboratory manufacturing and the clinic Edited by . Meyer A biotech manager s handbook A practical guide Edited by M. O Neill and . Hopkins Clinical research in Asia Opportunities and challenges U. Sahoo Therapeutic antibody engineering Current and future advances driving the strongest growth area in the pharma industry . Strohl and . Strohl Commercializing the stem cell sciences O. Harvey Published by Woodhead Publishing Limited .